Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June 2013 Volume 5 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June 2013 Volume 5 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions

  • Authors:
    • Xiao-Shan Feng
    • Yu-Feng Wang
    • Shu-Guang Hao
    • Yi Ru
    • She-Gan Gao
    • Li-Dong Wang
  • View Affiliations / Copyright

    Affiliations: Department of Oncology, Cancer Institute, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China, Henan Key Laboratory for Esophageal Cancer Research, College of Medicine, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
  • Pages: 1555-1558
    |
    Published online on: April 2, 2013
       https://doi.org/10.3892/etm.2013.1038
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to characterize histochemical patterns and Das-1 and Ki67 protein expression in gastric cardia adenocarcinoma (GCA) and intestinal metaplasia (IM) lesions adjacent to GCA. Histochemical techniques, including Alcian blue/periodic acid-Schiff (AB/PAS), high iron diamine/Alcian blue (HID/AB) and avidin‑biotin‑peroxidase complex (ABC) immunohistochemistry were applied to GCA and IM samples from patients (n=200) in Linzhou, Henan, China, a high incidence area for GCA and esophageal squamous cell carcinoma (SCC). The detection rate of IM lesions in resected tissues adjacent to GCA was 32.5% (65/200). GCA and IM lesions presented a high frequency of Das-1 and Ki67-positive staining with statistical significance (P<0.01). The expression of sulfuric proteins did not show co-expression with Das-1 and Ki67 in GCA and surrounding IM lesions (P>0.05) from the same GCA patient. The high frequency of co-expression of Das-1 and Ki67 in GCA and adjacent IM lesions indicates that IM adjacent to GCA may undergo similar molecular changes to GCA, which may be one of the mechanisms for malignant transformation of IM in the population studied.

Introduction

The epidemiology of gastric cardia adenocarcinoma (GCA) is characterized by a regional distribution identical to that of esophageal squamous cell carcinoma (SCC) (1). In Linzhou, northern China, the ratio of the incidence rates for GCA and SCC is ∼1:3.2 (2). Approximately 60% of patients with suspected SCC, who receive surgical treatment at Linzhou People's Hospital, are confirmed as having preliminary SCC and the remaining 40% have GCA (3). Furthermore, it is not a rare event in other high incidence areas for esophageal cancer (4). An epidemiological study has suggested that SCC and GCA share a similar pathogenesis of malignant transformation (5). The occurrence pattern of GCA is not similar to that of neoplasms originating from the distal parts of the stomach. In recent years, the incidence of gastric cancer has been declining (6), while that of GCA is tending to increase (7). In reference to variations in the epidemiology, etiology, pathophysiology and clinical parameters between GCA and cancer in the distal part of the stomach, we have proposed that GCA should be regarded as an independent disease (8,9).

Like other forms of cancer, GCA is a multi-step and progressive disease, which may require the involvement of the alterations of multiple genes (10). The resulting imbalance of homeostasis between tumor suppressor and oncogene is one of the key elements in this chronic disease (11,12). Although intestinal metaplasia (IM) is an inevitable step in the histopathological model for GCA, which begins with normal mucosa and progresses towards superficial cardia gastritis, atrophic cardia gastritis and/or interstitial metaplasia, dysphasia and finally to GCA (13), the underlying molecular mechanisms for this multi-step process are not clear. The present study aimed to examine the expression of sulfuric, Das-1 and Ki67 proteins in GCA and IM adjacent to GCA to enhance our understanding of the correlation between IM and GCA.

Materials and methods

GCA patients and sample collection

Surgically resected GCA samples from 200 patients (including 147 males and 53 females with a mean age of 59±9 years and an age range of 46–79 years) were collected from Linzhou People's Hospital, Linzhou Central Hospital and Esophageal Cancer Hospital of Yaocun, Linzhou in 2010. This study was conducted in accordance with the Declaration of Helsinki. This study was conducted with approval from the Ethics Committee of The First Affiliated Hospital of Henan University of Science and Technology. Written informed consent was obtained from all participants. No chemotherapy or radiotherapeutic regimens were undertaken for the patients involved in this study. All the samples were fixed with 95% ethanol. In addition to GCA tissue blocks, 10–15 tissue blocks adjacent to the GCA field were also dissected and then subjected to paraffin-embedding. Serial sections of 5 μm were cut for hematoxylin and eosin (H&E) staining, histochemistry and immunohistochemistry (IHC).

Histochemical staining

High iron diamine-Alcian blue (HID/AB) staining was performed according to the protocols established in our laboratory previously (14). In brief, deparaffinized sections were treated with high iron diamine for 24 h at room temperature followed by incubation with Alcian blue solution for 20–30 min in a humified chamber. After washing with distilled water, sections were treated with 0.5% neutral red solution (Shanghai No. 3 Reagent Factory, Shanghai, China) for 1–2 min and then washed as above. The slides were sealed with neutral gum. As for the avidin-biotin-peroxidase complex (ABC) method of IHC, slides were deparaffinized with xylene and dehydrated with serially graded ethanol followed by antigen retrieval by microwave boiling for 10 min. After washing with phosphate-buffered saline (PBS) three times for 5 min each, the slides were incubated with 0.5% H2O2 for 20 min to quench endogenous peroxidase. Normal horse serum at a dilution of 1:50 was added to each slide to block non-specific reactions and incubated for 20 min. Incubation with the primary mouse antibodies for Das-1 (Uscn Life Science Inc., Wuhan, China) and Ki67 (Oncogene Research, San Diego, CA, USA) was performed at 4°C overnight. The dilution of Das-1 was 1:50. Following incubation with biotinylated rabbit secondary antibody at a dilution of 1:200 for 45 mins and three washes with PBS, ABC solution at a dilution 1:50:50 was applied to each slide and incubated for 1 h. The positive results were visualized with 3,3′-diaminobenzidine (DAB). Finally, slides were mounted with neutral gum. During each batch of experiments, the control slide (without the primary antibody) was used to ensure the protocols were followed correctly.

Criteria for HID/AB and IHC analyses

The criterion for diagnosis using HID/AB has been established previously (15). The sulfuric mucous was detected as black staining while the sialic mucus appeared as blue staining in the cytoplasm and/or outside the cells under a microscope. For positive Das-1 staining, the cytoplasm presented brown staining and there was no staining in the nuclei. In accordance with Mirza et al(16), the expression of Das-1 was considered positive if a substantial number of cells and >1 gland were stained. If only an occasional goblet cell was stained, the sample was considered negative. With regard to the criterion for Ki67 staining, brown staining was observed exclusively in the nuclei of cells. Ki67 staining was classified according to the protocols reported by Yi (17): + represents <25% positively-stained cells, ++ indicates 26–50% positive cells, +++ indicates 51–75% positive cells and ++++ indicates >76% positively-stained cells in ten randomly selected fields under a microscope with ×400 magnification.

Statistical analysis

The κ consistency test was employed to evaluate the significance of statistical analyses. P<0.05 was considered to indicate a statistically significant difference.

Results

Detection rate of IM lesions adjacent to GCA

The detection rate of IM lesions in resected tissues adjacent to GCA was 65/200 (32.5%).

Ki67 protein expression in GCA and matched IM lesions

Ki67 expression was identified in GCA and in the adjacent IM of the same patient (Fig. 1 and Table I).

Figure 1

(A) Ki67 immunostaining of the gastric cardia adenocarcinoma (GCA). The nuclei demonstrated strong immunoreactivity (magnification, ×10). (B) Ki67 immunostaining of intestinal metaplasia lesions adjacent to the GCA. The nuclei demonstrated strong immunoreactivity (magnification, ×20).

Table I

Co-expression of Das-1, Ki67 and sulfuric proteins in GCA and matched adjacent IM lesions from the same patient.

Table I

Co-expression of Das-1, Ki67 and sulfuric proteins in GCA and matched adjacent IM lesions from the same patient.

GCA
Das-1 protein
Ki67 protein
Sulfuric protein
Positive n (%)Negative n (%)TotalPositive n (%)Negative n (%)TotalPositive n (%)Negative n (%)Total
IM (adjacent to GCA)Positive22 (48.75)3 (3.75)2520 (30.77)2 (3.08)2219 (29.23)19 (29.23)38
Negative9 (5.00)31 (42.50)4019 (29.23)24 (36.92)4310 (15.38)17 (26.15)27

[i] Das-1: κ=0.503, P<0.01; Ki67: κ=0.436, P<0.01; sulfuric protein: κ=0.129, P=0.322. GCA, gastric cardia adenocarcinoma; IM, intestinal metaplasia.

Das-1 protein expression in GCA and matched IM lesions

Similar to the expression pattern of Ki67, the Das-1 protein was identified in GCA and the adjacent IM of the same patient (Fig. 2 and Table I).

Figure 2

(A) Das-1 immunostaining of the gastric cardia adenocarcinoma (GCA). The positive immunoreactivity was located in the nuclei (magnification, ×10). (B) Das-1 immunostaining of intestinal metaplasia lesions adjacent to the GCA. Positive immunoreactivity was located in nuclei (magnification, ×20).

Sulfuric mucous protein in GCA and matched IM lesions

The sulfuric mucous protein was stained as black-brown in GCA following HID/AB staining. In the same patient, the sulfuric mucous protein did not show a pronounced co-expression tendency in GCA and surrounding IM tissues (Fig. 3 and Table I).

Figure 3

(A) Histochemical stain for sulfuric protein in gastric cardia adeno-carcinoma (GCA). The sulfuric mucous was detected as black staining, while the sialic mucous appeared as blue staining in the cytoplasm (magnification, ×20). (B) Histochemical stain for sulfuric protein in intestinal metaplasia (IM) lesions. The sulfuric mucous was detected as black staining, while the sialic mucous appeared as blue staining in the cytoplasm (magnification, ×20).

Discussion

The current study demonstrates the presence of Das-1 protein in GCA and the surrounding IM lesions. This finding implies that these two morphologically different lesions are homologous in terms of molecular alterations. GCA may originate from IM. Das-1 protein may contribute to the transformation from IM to GCA in this multi-stage process. Another finding of the present study was the co-expression of the Ki67 protein in GCA and the corresponding IM, which further supports our above hypothesis.

Das-1 (formerly known as 7E12H12) was developed against a 40-kDa colonic epithelial protein (18). It specifically recognizes a >200-kDa colon epithelial protein that complexes with a 40-kDa protein and acts as a chaperone to bring the 40-kDa protein to the colonic epithelial surface. Its role in cell proliferation, differentiation and carcinogenesis is unclear. Experimental data show that high Das-1 protein expression may be used to identify risk factors for the occurrence of cancer of cardia intestinal tissue.

The colonic type of IM, which contains sulfuric mucous protein, has more malignant features and has increased malignant potential. Morphologically, colonic IM is immature and/ or dedifferentiated with respect to histological structure and cell appearance. This type of IM is considered a manifestation of a typical cardia mucosa. The presence of a large quantity of sulfuric mucous protein in the glands is often indicative of aberrant gene expression. In IM lesions, a variety of tumor-associated antigens, including the Ras p21 oncogene product, are increasingly identified. In terms of genetic features, aneuploidal cells and the DNA content in the colonic type of IM increase with IM progression. Increasing evidence indicates that the colonic type of IM shares more biological characteristics with neoplastic cells than other type of IM (19). The present study also revealed that the detection rate of the colonic type of IM adjacent to GCA was increased compared with that in normal cardia mucosa. The sulfuric mucous protein, however, did not show the consistency as strikingly as Das-1 and Ki67 proteins, which demonstrate pronounced co-expression. The possible causes for the different expression patterns of sulfuric mucous protein may be as follows: i) IM containing sulfuric mucous protein, although readily prone to be transformed, has to undertake a multi-step process and clone selection prior to gaining malignant properties; ii) the number of samples involved in this study is limited and, therefore, a larger study is required; and iii) the correlation between the colonic type of IM and GCA requires in-depth investigation.

Currently, the mechanisms of carcinogenesis in the IM mucosa are not clear. The epithelial cells in IM and the enzymes within are able to take up lipids and lipid-soluble substances, in a similar manner to the intestinal epithelium; however, the epithelium of IM does not possess infrastructure-like chyle vessels for transporting these substances. These retained substances inside IM cells are highly carcinogenic and may contribute to the transformation (20). Previously, it was hypothesized that genes of stem cells in the proliferation center within a mucosal gland are mutated following stimulation, and the depression of colonic types of gene leads to the differentiation of stem cells towards colonic-type cells. Two types of IM, complete IM and incomplete IM, are formulated based on the mature or immature morphology of metaplasia. The lesions are likely to get worse if differentiation is aggravated and ultimately form a neoplasm (21).

In conclusion, these results not only increased our insight into the correlation between IM and GCA using histochemistry and IHC, but also provide a basis for the elucidation of the tumor-genesis mechanisms of GCA and the identification of highly-specific and highly-sensitive biomarkers for detection and early diagnosis. In combination with clinical practice, further studies are required to determine the importance of histochemical staining in the classification of GCA, to examine the correlation between grades of malignancy, lymphatic metastasis and various types of IM and to investigate the response sensitivity following radiotherapy and chemotherapy.

Acknowledgements

This study was supported by the National Outstanding Young Scientist Award of China (No. 30025016) and the National Natural Science Foundation of China (No. 30670956).

References

1. 

Abrams JA, Sharaiha RZ, Gonsalves L, Lightdale CJ and Neugut AI: Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940–2007. Cancer Epidemiol Biomarkers Prev. 20:183–186. 2011.PubMed/NCBI

2. 

Guanrei Y and Sunglian Q: Incidence rate of adenocarcinoma of the gastric cardia, and endoscopic classification of early cardial carcinoma in Henan Province, the People's Republic of China. Endoscopy. 19:7–10. 1987.PubMed/NCBI

3. 

Wang LD, Gao WJ, Yang WC, et al: Prelimary analysis of the statistics on 3933 cases with esophageal cancer and gastric cardia cancer from the subjects in the People's Hospital of Linzhou in 9 years. J Henan Med Univ. 32:9–11. 1997.(In Chinese).

4. 

Tinmouth J, Green J, Ko YJ, et al: A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation. J Gastrointest Surg. 15:782–790. 2011. View Article : Google Scholar : PubMed/NCBI

5. 

Wang LD: Mechanisms of human esophageal and gastric cardia multistage carcimegenesis. Zhonghua Zhong Liu Fang Zhi Za Zhi. 13:321–324. 2006.(In Chinese).

6. 

Coupland VH, Allum W, Blazeby JM, et al: Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer. 12:112012. View Article : Google Scholar : PubMed/NCBI

7. 

Fan YJ, Song X, Li JL, et al: Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J Surg. 32:1980–1988. 2008.PubMed/NCBI

8. 

Gertler R, Stein HJ, Loos M, Langer R, Friess H and Feith M: How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol. 35:1512–1522. 2011. View Article : Google Scholar : PubMed/NCBI

9. 

Yamashita H, Katai H, Morita S, Saka M, Taniguchi H and Fukagawa T: Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg. 254:274–280. 2011. View Article : Google Scholar : PubMed/NCBI

10. 

Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS and Sampliner RE: Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut. 46:9–13. 2000. View Article : Google Scholar : PubMed/NCBI

11. 

Sugimura T: Multistep carcinogenesis: a 1992 perspective. Science. 258:603–607. 1992. View Article : Google Scholar : PubMed/NCBI

12. 

Weinberg RA: How cancer arises. Sci Am. 275:62–70. 1996. View Article : Google Scholar

13. 

Zhou Q and Wang LD: The studies on the biological characteristics of gastric cardia carcinoma. World J Gastroenterol. 6:636–637. 1998.(In Chinese).

14. 

Chen H, Wang LD, Fan ZM, Gao SG, Guo HQ and Guo M: The comparison study of the three histochemical staining methods in gastric cardia intestinal metaplasia staining. Henan Med Res. 12:10–13. 2003.(In Chinese).

15. 

Gao SG, Wang LD, Fan ZM, et al: Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol. 11:4634–4637. 2005.PubMed/NCBI

16. 

Mirza ZK, Das KK, Slate J, et al: Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut. 52:807–812. 2003. View Article : Google Scholar : PubMed/NCBI

17. 

Yi XP: The advances in application researching on estimating prognosis of carcinoma with immunohistochemical method. Cancer Res Prev Treat. 23:382–385. 1996.(In Chinese).

18. 

Das KM, Sakamaki S, Vecchi M and Diamond B: The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol. 139:77–84. 1987.

19. 

Zullo A, Hassan C, Romiti A, et al: Follow-up of intestinal meta-plasia in the stomach: When, how and why. World J Gastrointest Oncol. 4:30–36. 2012. View Article : Google Scholar : PubMed/NCBI

20. 

Correa P: Is gastric cancer preventable? Gut. 53:1217–1219. 2004. View Article : Google Scholar : PubMed/NCBI

21. 

Tang LJ: Review of research on gastric intestinal metaplasia. J Prac Oncol. 10:77–79. 1996.(In Chinese).

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Feng X, Wang Y, Hao S, Ru Y, Gao S and Wang L: Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. Exp Ther Med 5: 1555-1558, 2013.
APA
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., & Wang, L. (2013). Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. Experimental and Therapeutic Medicine, 5, 1555-1558. https://doi.org/10.3892/etm.2013.1038
MLA
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., Wang, L."Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions". Experimental and Therapeutic Medicine 5.6 (2013): 1555-1558.
Chicago
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., Wang, L."Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions". Experimental and Therapeutic Medicine 5, no. 6 (2013): 1555-1558. https://doi.org/10.3892/etm.2013.1038
Copy and paste a formatted citation
x
Spandidos Publications style
Feng X, Wang Y, Hao S, Ru Y, Gao S and Wang L: Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. Exp Ther Med 5: 1555-1558, 2013.
APA
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., & Wang, L. (2013). Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. Experimental and Therapeutic Medicine, 5, 1555-1558. https://doi.org/10.3892/etm.2013.1038
MLA
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., Wang, L."Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions". Experimental and Therapeutic Medicine 5.6 (2013): 1555-1558.
Chicago
Feng, X., Wang, Y., Hao, S., Ru, Y., Gao, S., Wang, L."Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions". Experimental and Therapeutic Medicine 5, no. 6 (2013): 1555-1558. https://doi.org/10.3892/etm.2013.1038
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team